WHO's Updated Covid-19 Treatment Guidelines

The World b Health Organization (WHO) has revised its guidelines for Covid-19 therapeutics, providing updated recommendations for patients with non-severe Covid-19. These guidelines have been updated for the 13th time. The hospital admission risk rates for patients with non-severe Covid-19 have been updated. The guidance now includes the latest risk rates for non-severe Covid-19 patients who may require hospital admission.

The latest Covid-19 virus strains are resulting in less severe illness and decreased risk of death for most patients, thanks to higher immunity levels from vaccination. The new update features updated baseline risk estimates for hospital admission in patients with non-severe Covid-19. The newly defined 'moderate risk' category now encompasses individuals who were previously considered high risk, such as older individuals and those with chronic conditions, disabilities, and co morbidities of chronic disease. Healthcare professionals can use the new risk estimates to determine which individuals are at high, moderate, or low risk of hospital admission. This will help them customize treatment based on WHO guidelines. People with weakened immune systems are at greater risk if they get Covid-19, with around 6% of them needing to be hospitalized. Those who are 65 and older, obese, diabetic, or have chronic medical conditions such as COPD, kidney or liver disease , or cancer, as well as individuals with disabilities or co morbidities, are considered to be at moderate risk. The estimated hospitalization rate for this group is 3%.